Results 71 to 80 of about 795 (185)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis

open access: yesJournal of Orthopaedic Surgery and Research, 2020
Background Osteoporosis is a metabolic bone disease. Bisphosphonate (BP) and eldecalcitol (ELD) are two clinical first-line drugs for osteoporosis patients. However, the effect of ELD + BP vs. BP alone on osteoporosis treatment is still unclear.
Zaoqian Zheng, Jinyu Luo
doaj   +1 more source

High frequency:Low frequency ratios over time.

open access: yes, 2015
(A) capecitabine, (B) eldecalcitol, (C) epoetin beta pegol, (D) peginterferon alfa-2a, and (E) sevelamer hydrochloride.
Seigo Okugawa (733308)   +10 more
core   +1 more source

Simultaneous Total Hip Arthroplasty and Plate Fixation for Ipsilateral Subtrochanteric Fracture Following Femoral Neck Osteosynthesis

open access: yesCase Reports in Orthopedics, Volume 2025, Issue 1, 2025.
Background Subtrochanteric fracture is a recognized complication following osteosynthesis for femoral neck fractures, typically occurring within 1–2 months postoperatively. At the time of onset, incomplete healing of the femoral neck fracture often results in a complex fracture configuration that poses challenges for management.
Hirokazu Takai   +8 more
wiley   +1 more source

Eldecalcitol, in Combination with Bisphosphonate, Is Effective for Treatment of Japanese Osteoporotic Patients

open access: yesThe Tohoku Journal of Experimental Medicine, 2015
Alfacalcidol (ALF) and eldecalcitol (ELD) are vitamin D analogues that can be combined with anti-resorption drugs, such as bisphosphonate (BP) for the treatment of osteoporosis (OP). There has been no report comparing the effects of those vitamin D analogs in combination with BPs.
Mukaiyama, Keijiro   +6 more
openaire   +3 more sources

Exendin-4 and eldecalcitol synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells through M2 macrophages polarization via PI3K/AKT pathway

open access: yesStem Cell Research & Therapy, 2022
Background The incidence of diabetic osteoporosis is increasing. This article evaluates the effect of combination treatment with the hypoglycemic drug exendin-4 (Ex-4) and the vitamin D analog eldecalcitol (ED-71) on improving diabetic osteoporosis and ...
Yupu Lu   +6 more
doaj   +1 more source

Adverse drug reaction reporting trend for 5 drugs.

open access: yes, 2015
Total number of individual case safety reports for (A) capecitabine, (B) eldecalcitol, (C) epoetin beta pegol, (D) peginterferon alfa-2a, and (E) sevelamer hydrochloride.
Seigo Okugawa (733308)   +10 more
core   +1 more source

Guideline for gynecological practice in Japan: Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists 2023 edition

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 50, Issue 7, Page 1073-1094, July 2024.
Abstract Twelve years after the first edition of The Guideline for Gynecological Practice, which was jointly edited by The Japan Society of Obstetrics and Gynecology and The Japan Association of Obstetricians and Gynecologists, the 5th Revised Edition was published in 2023.
Eiji Nishio   +35 more
wiley   +1 more source

The proportion of adverse drug reactions reported to the manufacturer within 2 weeks of onset.

open access: yes, 2015
(A) capecitabine, (B) eldecalcitol, (C) epoetin beta pegol, (D) peginterferon alfa-2a, and (E) sevelamer hydrochloride. Error bars represent the 95% confidence intervals.
Seigo Okugawa (733308)   +10 more
core   +1 more source

Pyoderma gangrenosum‐like lesions in the setting of IgA cutaneous vasculitis: Favourable response to adalimumab

open access: yesSkin Health and Disease, Volume 4, Issue 2, April 2024.
Pyoderma gangrenosum is a rare inflammatory skin disease classified within the group of neutrophilic dermatoses, and clinically characterised by painful, rapidly evolving cutaneous ulcers with undermined, irregular, erythematous‐violaceous edges. Underlying diseases include rheumatoid arthritis, inflammatory bowel disease, haematopoietic malignancy ...
Hitomi Sugino   +4 more
wiley   +1 more source

Pd(0)‐Catalyzed‐Mediated Synthesis of Vitamin D Compounds

open access: yesAdvanced Synthesis &Catalysis, Volume 366, Issue 4, Page 603-616, February 20, 2024.
Abstract 1α,25‐Dihydroxyvitamin D3 (1,25D3), the hormonally active form of vitamin D3, regulates mineral homeostasis, cell growth, cell differentiation‐proliferation, apoptosis, and immune responses. 1,25D3 activates more than 229 genes associated with several diseases, including arthritis, diabetes and cancer, suggesting its implications in a broader ...
Antonio Mouriño
wiley   +1 more source

Home - About - Disclaimer - Privacy